PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 7 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

2 June 2026

  1. (diff | hist) 09:40 Talk:Active pharmaceutical ingredient 537 +138 GMP_Gita (talk | contribs) /* Same line as pharmaceutical material */ new section
  2. (diff | hist) m 03:31 Purity claim inflation 5,660 ±0 PuffRemoverPax (talk | contribs) space between number and unit per PP:MOS [rollback]

1 June 2026

  1. (diff | hist) m 22:30 Gastric emptying 5,565 ±0 BetaCellBoyd (talk | contribs) split §Physiology from §Pharmacological exploitation [rollback]
  2. (diff | hist) 14:00 Talk:Placebo-adjusted effect 748 +90 SurrogateSunday (talk | contribs) /* Blinding failure */ reply
  3. (diff | hist) 13:50 Talk:Prescribing information 748 +60 ScopeSeverin (talk | contribs) /* No label for research material */ reply
  4. (diff | hist) 13:15 Talk:Chain of custody 885 +124 ColdChainCleo (talk | contribs) /* Storage confound */ reply
  5. (diff | hist) 10:25 Talk:Placebo-adjusted effect 537 +134 PreregPriya (talk | contribs) /* Blinding failure */ new section
  6. (diff | hist) 10:15 Talk:Prescribing information 537 +154 DisclosureDido (talk | contribs) /* No label for research material */ new section
  7. (diff | hist) 09:50 Talk:Chain of custody 674 +139 StabilityStig (talk | contribs) /* Storage confound */ new section
  8. (diff | hist) m 05:05 Multi-dose vial 24,688 ±0 LipidLedgerLou (talk | contribs) the vial strength in the example was inconsistent between two paragraphs [rollback]

31 May 2026

  1. (diff | hist) 14:40 Talk:Reference standard 885 +140 Retention_Time_Rae (talk | contribs) /* Co-injection */ reply
  2. (diff | hist) 13:50 Talk:Timeline of incretin therapeutics 748 +73 TimelineTiernan (talk | contribs) /* Approval dates are jurisdictional */ reply
  3. (diff | hist) m 11:47 Counterfeit peptide 5,488 ±0 COA_Colwyn (talk | contribs) label the community tally as self-reported at this point of use as well [rollback]
  4. (diff | hist) 11:15 Talk:Reference standard 674 +123 IsocraticIla (talk | contribs) /* Co-injection */ new section
  5. (diff | hist) 10:38 Haemoglobin A1c 4,243 ±0 HedgeHedda (talk | contribs) clarify that the reference interval is not a treatment target [rollback]
  6. (diff | hist) 10:15 Talk:Timeline of incretin therapeutics 537 +106 LabelLibby (talk | contribs) /* Approval dates are jurisdictional */ new section
  7. (diff | hist) 10:03 Sharps disposal 11,037 +1,605 ReceptorRhoda (talk | contribs) add the diluent volume the example assumes [rollback]

30 May 2026

  1. (diff | hist) m 23:49 Peptide supply chain 8,410 ±0 RepackRadek (talk | contribs) split overlong sentence [rollback]
  2. (diff | hist) 21:12 Shanghai Sigma-Audley New Material Technology 15,579 ±0 DeadSpaceDot (talk | contribs) rm the price; supplier articles carry no price per PP:VN [rollback]
  3. (diff | hist) 17:50 Hubei Jianxiang Bioscience 14,855 ±0 BlankVialBo (talk | contribs) correct the other-designations row — those are trading variants, not subsidiaries [rollback]
  4. (diff | hist) 14:49 Peptide aggregation 5,516 ±0 LotTraceLuka (talk | contribs) space between number and unit per PP:MOS [rollback]
  5. (diff | hist) 13:15 Talk:Sterile water for injection 748 +107 TFA_Counterion (talk | contribs) /* Unbuffered pH */ reply
  6. (diff | hist) 12:50 Talk:CagriSema 885 +168 COA_Colwyn (talk | contribs) /* Two powders in proportion */ reply
  7. (diff | hist) 09:40 Talk:Sterile water for injection 537 +147 DiluentDiya (talk | contribs) /* Unbuffered pH */ new section
  8. (diff | hist) 09:35 Talk:CagriSema 674 +151 VerifyVesna (talk | contribs) /* Two powders in proportion */ new section
  9. (diff | hist) m 09:30 WuXi TIDES 16,434 ±0 CustomsClarke (talk | contribs) expand §Reception [rollback]
  10. (diff | hist) 08:33 Sharps disposal 9,432 +1,192 RetinopathyRex (talk | contribs) add the preservative point: unpreserved diluent changes the interval [rollback]
  11. (diff | hist) m b 08:17 Adverse effects of GLP-1 receptor agonists 5,791 ±0 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  12. (diff | hist) 00:25 ChinaPeptides 14,979 ±0 TrialsTabitha (talk | contribs) add the lead time for catalogue lines, as reported [rollback]

29 May 2026

  1. (diff | hist) 21:09 Shanghai ERP Biotechnology 14,637 ±0 CheckSumChase (talk | contribs) add the transit window each regional warehouse serves [rollback]
  2. (diff | hist) m b 16:34 Flourishglobal Peptide Biotech 14,771 ±0 CiteBot (talk | contribs) bot: mark outbound storefront link nofollow [rollback]
  3. (diff | hist) 16:11 Prior authorisation 4,216 ±0 SerialCommaSeb (talk | contribs) give the cost per unit of effect rather than only the cost [rollback]
  4. (diff | hist) 13:55 Talk:Cagrilintide 748 +63 COA_Colwyn (talk | contribs) /* Aggregation and method coverage */ reply
  5. (diff | hist) 10:20 Talk:Cagrilintide 537 +175 StabilityStig (talk | contribs) /* Aggregation and method coverage */ new section
  6. (diff | hist) 02:28 Trial data comparison 7,303 ±0 DeletionDeb (talk | contribs) copyedit [rollback]

28 May 2026

  1. (diff | hist) m 18:48 Bachem Holding (Suzhou) 15,124 ±0 UnderfillUna (talk | contribs) add the storage and handling guidance the organisation publishes [rollback]
  2. (diff | hist) 14:05 Talk:FLOW trial 748 +126 LabRangeLindy (talk | contribs) /* The initial eGFR dip */ reply
  3. (diff | hist) 13:45 Talk:Trifluoroacetate counterion 748 +163 Peptide_Pete (talk | contribs) /* Assay interference claim */ reply
  4. (diff | hist) 12:55 Talk:Tirzepatide 885 +233 GradientGus (talk | contribs) /* Deletion sequences and co-elution */ reply
  5. (diff | hist) 10:58 Cold chain 27,220 ±0 GastroparesisGwen (talk | contribs) add the customs-detention point as a logistics fact, sourced [rollback]
  6. (diff | hist) 10:30 Talk:FLOW trial 537 +150 eGFR_Esme (talk | contribs) /* The initial eGFR dip */ new section
  7. (diff | hist) 10:15 Talk:Trifluoroacetate counterion 537 +176 PrimarySrcPatia (talk | contribs) /* Assay interference claim */ new section
  8. (diff | hist) 09:33 Talk:Tirzepatide 674 +184 Chromatokid (talk | contribs) /* Deletion sequences and co-elution */ new section
  9. (diff | hist) 08:34 Peptide stability table 6,886 ±0 MergeMorwenna (talk | contribs) add the cross-link from the calculator to the unit-conversion article [rollback]
  10. (diff | hist) 03:14 Chinese Peptide Company 15,513 ±0 IncretinIvo (talk | contribs) convert the product range to a table so the documentation column lines up [rollback]
  11. (diff | hist) m 03:02 Shenzhen Hybio Pharmaceutical 17,716 ±0 ReportReaderRilla (talk | contribs) add the transit window each regional warehouse serves [rollback]
  12. (diff | hist) 00:44 Sharps disposal 8,240 +1,675 A1c_Alder (talk | contribs) expand §Scope and definitions [rollback]
  13. (diff | hist) m b 00:06 VendorInvestigate 5,067 ±0 CategoryBot (talk | contribs) bot: sort category members [rollback]

27 May 2026

  1. (diff | hist) m 14:29 Research use only 7,990 ±0 PortalPolly (talk | contribs) ce, tighten prose [rollback]
  2. (diff | hist) 13:55 Talk:Good manufacturing practice 748 +132 COA_Colwyn (talk | contribs) /* The uncomfortable inference */ reply
  3. (diff | hist) 13:00 Talk:VendorInvestigate 885 +135 CustomsClarke (talk | contribs) /* Registration checks and jurisdiction */ reply
  4. (diff | hist) 10:20 Talk:Good manufacturing practice 537 +175 BalanceBirdie (talk | contribs) /* The uncomfortable inference */ new section
  5. (diff | hist) 09:30 Talk:VendorInvestigate 674 +168 ImportRecordIna (talk | contribs) /* Registration checks and jurisdiction */ new section
  6. (diff | hist) 06:45 Amylin 5,795 ±0 LiraLotte (talk | contribs) ce [rollback]
  7. (diff | hist) 06:31 Retatrutide 7,421 ±0 TimelineTiernan (talk | contribs) give the strength per pen as well as per millilitre [rollback]
  8. (diff | hist) 06:15 AmbioPharm 17,173 ±0 ForgeryFinder (talk | contribs) add the reception tally with its period and count stated [rollback]

26 May 2026

  1. (diff | hist) m 18:02 Sigma-Aldrich (Shanghai) Trading 18,641 ±0 Chromatokid (talk | contribs) correct the regional-warehouse list — six sites, not five [rollback]
  2. (diff | hist) 14:04 Cost per milligram 4,125 ±0 TelehealthTruus (talk | contribs) add the cross-link to the insurance article [rollback]
  3. (diff | hist) 13:55 Talk:Hypoglycaemia 748 +100 DisclosureDido (talk | contribs) /* Unknown exposure */ reply
  4. (diff | hist) m 13:33 Test report forgery 5,391 ±0 GramsNotUnitsGil (talk | contribs) clarify that agreement between certificate and report is a weak finding [rollback]
  5. (diff | hist) 10:20 Talk:Hypoglycaemia 537 +178 COA_Colwyn (talk | contribs) /* Unknown exposure */ new section
  6. (diff | hist) 08:40 Syringe dead space 20,968 ±0 TitrationTheo (talk | contribs) the rounding in the table lost a decimal place that matters at low doses [rollback]
  7. (diff | hist) 08:33 Sharps disposal 6,565 +674 SyringeSybille (talk | contribs) clarify that the figure is per dose, not per vial [rollback]
  8. (diff | hist) 07:45 Underfilling 4,882 ±0 AnalyticalAnnie (talk | contribs) ce [rollback]
  9. (diff | hist) 04:47 Body composition assessment 5,029 ±0 PlainNumbersPip (talk | contribs) rm the diagnostic threshold — the article describes, it does not diagnose [rollback]
  10. (diff | hist) m 03:35 GenScript Peptides 17,833 ±0 SecondarySrc_Seb (talk | contribs) add the catalogue size and label it self-reported [rollback]
  11. (diff | hist) 02:39 Baseline laboratory panel 4,429 ±0 BaselineBex (talk | contribs) rm the claim that the marker predicts outcome; the cited study is cross-sectional [rollback]

25 May 2026

  1. (diff | hist) 19:53 GLP-1 receptor agonist 11,264 ±0 UACR_Ulric (talk | contribs) the storage condition applies to the unopened pen; say so [rollback]
  2. (diff | hist) 15:34 Sharps disposal 5,891 +1,452 GradientGus (talk | contribs) state that swirling rather than shaking is the handling convention, sourced [rollback]
  3. (diff | hist) 14:05 Talk:Receptor bias 748 +60 TirzTaxonomist (talk | contribs) /* Two senses of bias */ reply
  4. (diff | hist) 14:00 Talk:Injection site rotation 748 +92 RotationRosalind (talk | contribs) /* Site logs */ reply
  5. (diff | hist) m b 13:40 Contract development and manufacturing organisation 5,011 ±0 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  6. (diff | hist) 12:15 Talk:Satiety signalling 885 +218 ArcuateArt (talk | contribs) /* Decerebrate preparations */ reply
  7. (diff | hist) m 10:58 Active pharmaceutical ingredient 4,569 ±0 IncretinIvo (talk | contribs) add the effective date to the regulatory table [rollback]
  8. (diff | hist) 10:30 Talk:Receptor bias 537 +185 ReceptorRhoda (talk | contribs) /* Two senses of bias */ new section
  9. (diff | hist) 10:15 Talk:Injection site rotation 537 +185 ClinicCorrespondent (talk | contribs) /* Site logs */ new section
  10. (diff | hist) m 10:07 Solid-phase peptide synthesis 5,359 ±0 IncretinIvo (talk | contribs) give the vial sizes in millilitres of nominal capacity [rollback]
  11. (diff | hist) 09:40 Talk:Satiety signalling 674 +133 StudentSindhu (talk | contribs) /* Decerebrate preparations */ new section
  12. (diff | hist) m b 08:27 Trifluoroacetate counterion 5,116 ±0 CategoryBot (talk | contribs) bot: repair redlinked category [rollback]
  13. (diff | hist) 08:06 GL Biochem (Shanghai) 16,491 ±0 PurityClaimPia (talk | contribs) add the note that this wiki publishes no score and no league table [rollback]
  14. (diff | hist) 04:40 Proglucagon 6,709 ±0 AmylinAmos (talk | contribs) ce, tighten prose [rollback]
  15. (diff | hist) 02:07 Grey market 4,279 ±0 ColdChainCleo (talk | contribs) add the stopper material, since it affects moisture ingress [rollback]
  16. (diff | hist) 02:04 Sarcopenia 4,491 ±0 Chromatokid (talk | contribs) rm the extrapolation from a research assay to a clinical one [rollback]
  17. (diff | hist) m b 01:53 MOTS-c 4,670 ±0 CiteBot (talk | contribs) bot: add stub category [rollback]
  18. (diff | hist) m b 00:00 Beyond-use date 23,171 ±0 ArchiveBot (talk | contribs) bot: add stub category [rollback]

24 May 2026

  1. (diff | hist) m 20:42 Chain of custody 5,157 ±0 BlindSampleBrid (talk | contribs) add the cost basis, since it shapes who submits [rollback]
  2. (diff | hist) 20:10 Semaglutide 10,355 ±0 PharmDrafts (talk | contribs) the lead claimed weekly dosing for a compound dosed daily; corrected [rollback]
  3. (diff | hist) 16:00 Subcutaneous injection 5,293 ±0 SPPS_Sorrel (talk | contribs) add the diluent volume the example assumes [rollback]
  4. (diff | hist) 13:50 Talk:ISO 9001 748 +101 GMP_Gita (talk | contribs) /* Accredited versus unaccredited bodies */ reply
  5. (diff | hist) m 13:36 Mass spectrometry 5,612 ±0 BacWaterBarnaby (talk | contribs) clarify that area percent is not mass percent [rollback]
  6. (diff | hist) 12:55 Talk:USP General Chapter 85 748 +142 Chromatokid (talk | contribs) /* Numbering convention */ reply
  7. (diff | hist) 11:26 Global access disparity 4,391 ±0 BPC_Bramwell (talk | contribs) add the prior-authorisation criterion as attributed to the payer document [rollback]
  8. (diff | hist) 10:15 Talk:ISO 9001 537 +146 DMF_Dermot (talk | contribs) /* Accredited versus unaccredited bodies */ new section
  9. (diff | hist) m 09:49 Lyophilisation 28,679 ±0 AmylinAmos (talk | contribs) the article confused primary and secondary drying; corrected [rollback]
  10. (diff | hist) 09:20 Talk:USP General Chapter 85 537 +183 StudentSindhu (talk | contribs) /* Numbering convention */ new section

23 May 2026

  1. (diff | hist) 21:56 Sharps disposal 4,439 +2,399 NotabilityNoa (talk | contribs) add the note that a smaller diluent volume raises concentration, not dose [rollback]
  2. (diff | hist) m b 18:56 Bacterial endotoxin test 5,317 ±0 CategoryBot (talk | contribs) bot: repair redlinked category [rollback]
  3. (diff | hist) 14:39 Exenatide 5,754 ±0 OralSemaOswin (talk | contribs) add short description [rollback]
  4. (diff | hist) m 10:12 Dose escalation schedule 4,993 ±0 DeletionDeb (talk | contribs) rm the titration schedule — that belongs on the compound article [rollback]
  5. (diff | hist) 09:59 Area percent purity 8,537 ±0 ColumnOvenCoy (talk | contribs) fix the anchor on an internal link [rollback]